Literature DB >> 17154262

Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells.

Jun Wang1, Andreea Ioan-Facsinay, Ellen I H van der Voort, Tom W J Huizinga, René E M Toes.   

Abstract

Foxp3 plays a key role in CD4+ CD25+ T(reg) cell function in mice and represents a specific marker for these cells. Despite the strong association between FOXP3 expression and regulatory function in fresh human T cells, little is known about the dynamics of endogenous FOXP3 expression and its relation to the suppressive function in activated human T cells. Here, we addressed the dynamics of FOXP3 expression during human CD4+ T cell activation by plate-bound anti-CD3 Ab as well as the relationship between its expression and regulatory function at the single-cell level. Our data show that FOXP3 is expressed in a high percentage of activated T cells after in vitro stimulation of human CD4+ CD25- cells. FOXP3 expression is strongly associated with hyporesponsiveness of activated T cells, but is not directly correlated with their suppressive capabilities, as we demonstrate that it is also expressed in activated nonsuppressive T cells. However, in this nonsuppressive T cell population, FOXP3 expression is transient, while it is stably expressed in activated T cells that do display suppressive function, and in natural CD4+ CD25++ T(reg) cells. These data indicate that expression of endogenous FOXP3, in humans, is not sufficient to induce regulatory T cell activity or to identify T(reg) cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17154262     DOI: 10.1002/eji.200636435

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  398 in total

1.  Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination.

Authors:  Matteo Vergati; Vittore Cereda; Ravi A Madan; James L Gulley; Ngar-Yee Huen; Connie J Rogers; Kenneth W Hance; Philip M Arlen; Jeffrey Schlom; Kwong Y Tsang
Journal:  Cancer Immunol Immunother       Date:  2010-10-26       Impact factor: 6.968

Review 2.  Histone/protein deacetylases and T-cell immune responses.

Authors:  Tatiana Akimova; Ulf H Beier; Yujie Liu; Liqing Wang; Wayne W Hancock
Journal:  Blood       Date:  2012-01-12       Impact factor: 22.113

Review 3.  The biology of FoxP3: a key player in immune suppression during infections, autoimmune diseases and cancer.

Authors:  Frances Mercer; Derya Unutmaz
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

4.  Inflammation: TREG cell control of autoimmune inflammation: a matter of timing?

Authors:  Hendrik Schulze-Koops; Alla Skapenko
Journal:  Nat Rev Rheumatol       Date:  2010-11       Impact factor: 20.543

5.  Perspectives on Regulatory T Cell Therapies.

Authors:  Michael Probst-Kepper; Andrea Kröger; Henk S P Garritsen; Jan Buer
Journal:  Transfus Med Hemother       Date:  2009-09-10       Impact factor: 3.747

6.  CD4+ CD25+ but not CD4+ Foxp3+ T cells as a regulatory subset in primary biliary cirrhosis.

Authors:  Dandan Wang; Huayong Zhang; Jun Liang; Zhifeng Gu; Qiang Zhou; Xiangshan Fan; Yayi Hou; Lingyun Sun
Journal:  Cell Mol Immunol       Date:  2010-08-23       Impact factor: 11.530

Review 7.  Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3+ regulatory T cells.

Authors:  Mark D Mannie; Kayla B DeOca; Alexander G Bastian; Cody D Moorman
Journal:  Cell Immunol       Date:  2020-07-15       Impact factor: 4.868

Review 8.  Helminth infections and host immune regulation.

Authors:  Henry J McSorley; Rick M Maizels
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.

Authors:  Madhav D Sharma; Babak Baban; Phillip Chandler; De-Yan Hou; Nagendra Singh; Hideo Yagita; Miyuki Azuma; Bruce R Blazar; Andrew L Mellor; David H Munn
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 10.  Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.

Authors:  Prabhakaran Kumar; Shikha Saini; Saad Khan; Swarali Surendra Lele; Bellur S Prabhakar
Journal:  Cell Immunol       Date:  2018-09-29       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.